Articles of Malaysia

News »

Malaysian firm to market Cuban vaccine against cancer

vacuna Malasia

Malaysian biotechnology firm Bioven, which is currently undertaking Phase III clinical trials of a promising Cuban vaccine against cancer, plans to list the medicine on the London stock exchange, following a fruitful collaboration with Cuba. The relationship of the Caribbean country with Bioven, a company in which the Malaysian government is one of the major shareholders, is an example of South-South cooperation, Elnartd Blanco, commercial manager of CIMAB, the distributor for the Cuban Center of Molecular Immunology (CIM), who created the vaccine, told Prensa Latina.